FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Wockhardt Metoprolol Succinate Recall

Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottl…

Wockhardt Usa Inc. · Parsippany, NJ

Risk level
Class II
Reported by FDA
Aug 27, 2014
Recall ID
D-1541-2014
Check your lot numberHow we source this data

Summary

Wockhardt recalled Wockhardt Metoprolol Succinate starting Jul 24, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1541-2014 on Aug 27, 2014. Reason: Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.

Product description

Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b) 500-count bottle (NDC 64679-737-03) Rx only, Manufactured by: Wockhardt Limited Mumbai, India Distributed by: Wockhardt USA LLC 20 Waterview Boulevard. Parsippany, NJ 07054 USA

Lot numbers, UPCs & expiration codes

Lot # a) LN11005, Exp 04/15; LN11006; Exp 04/15; b) LN10979; Exp. 04/15, LN10980; Exp. 04/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1541-2014
Classification
Class II
Status
Terminated
Recall initiated
Jul 24, 2014
FDA report date
Aug 27, 2014
Quantity
11,661 HDPE bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Wockhardt Usa Inc.

Original FDA data

Every field from FDA enforcement report D-1541-2014, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
68941
Address
20 Waterview Blvd., Suite 3
Code information
Lot # a) LN11005, Exp 04/15; LN11006; Exp 04/15; b) LN10979; Exp. 04/15, LN10980; Exp. 04/15
Postal code
07054
Report date
Aug 27, 2014
Product type
Drugs
Recall number
D-1541-2014
Classification
Class II
Recalling firm
Wockhardt Usa Inc.
Product quantity
11,661 HDPE bottles
Termination date
Nov 20, 2015
Reason for recall
Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b) 500-count bottle (NDC 64679-737-03) Rx only, Manufactured by: Wockhardt Limited Mumbai, India Distributed by: Wockhardt USA LLC 20 Waterview Boulevard. Parsippany, NJ 07054 USA
Distribution pattern
Nationwide
Recall initiation date
Jul 24, 2014
Initial firm notification
Letter
Center classification date
Aug 18, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1541-2014, published Aug 27, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls